Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?

Fondation Hôpital Saint-Joseph

Status: Completed

Conditions: Anal Carcinoma

Treatments: Diagnostic Test: MRI sequence

Study type: Observational

Funder types: Other

Identifiers

NCT03469596

IRMcanalANAL

Details and patient eligibility

About

Anal canal cell carcinoma is a very rare cancer but well treated. If the morphological test are well established in the initial evaluation, it's not the case of the follow up evaluation particularly by MRI.About 1/3 of patient decline with metastatic relapse during the follow up of these patients.It appears that clinical regression seen precociously is a predictive factor of survival without relapse. But there 's no study confirming that point.

This context takes us to evaluate if there is a predictive factor in MRI to final clinical result.

Enrollment: 87 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patient with anal canal cell carcinoma histologically proved
• patient with initial MRI and follow up MRI in Hospital St Joseph's radiology yard.
• patient for whom a radio chemotherapy treatment decision was taken.

Exclusion criteria

• patients with already metastatic lesions